CP-868596 (Crenolanib)
-
Technical Data
Description
CP-868596 (Crenolanib) is an orally bioavailable small molecule, targeting the platelet-derived growth factor receptor (PDGFR) with potential antineoplastic activity. CP-868596 also potently inhibits FLT3, sensitive to D842V mutation not V561D mutation.